This company seems to have been delisted
Reason: Rebranded as Cencora
Last recorded trade on: November 1, 2023
Source: https://www.amerisourcebergen.com/newsroom/press-releases/amerisourcebergen-announces-intent-to-change-name
Reason: Rebranded as Cencora
Last recorded trade on: November 1, 2023
Source: https://www.amerisourcebergen.com/newsroom/press-releases/amerisourcebergen-announces-intent-to-change-name
AmerisourceBergen
ABC
$179.98
Share price
-0.23%
Change (1 day)
16.32%
Change (1 year)
Categories
AmerisourceBergen Corporation is an American drug wholesale company.
Revenue for AmerisourceBergen (ABC)
Revenue in 2023 (TTM): $254.42 Billion USD
According to AmerisourceBergen
's latest financial reports the company's current revenue (TTM 
) is $254.42 Billion USD. In 2022 the company made a revenue of $241.80 Billion USD an increase over the revenue in the year 2021 that were of $221.10 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for AmerisourceBergen from 1996 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $254.42 B | 5.22% |
| 2022 | $241.80 B | 9.36% |
| 2021 | $221.10 B | 13.65% |
| 2020 | $194.54 B | 6.86% |
| 2019 | $182.06 B | 5.32% |
| 2018 | $172.86 B | 11.21% |
| 2017 | $155.44 B | 4.81% |
| 2016 | $148.30 B | 6.63% |
| 2015 | $139.08 B | 12.18% |
| 2014 | $123.98 B | 29.05% |
| 2013 | $96.07 B | 19.21% |
| 2012 | $80.59 B | -0.12% |
| 2011 | $80.68 B | 2.78% |
| 2010 | $78.50 B | 6.44% |
| 2009 | $73.75 B | 4.86% |
| 2008 | $70.33 B | 5.42% |
| 2007 | $66.72 B | 5.45% |
| 2006 | $63.27 B | 13.81% |
| 2005 | $55.59 B | 3.99% |
| 2004 | $53.46 B | 5.7% |
| 2003 | $50.57 B | 8.54% |
| 2002 | $46.60 B | 94.55% |
| 2001 | $23.95 B | 97.75% |
| 2000 | $12.11 B | 15.61% |
| 1999 | $10.47 B | 22.06% |
| 1998 | $8.58 B | 3.13% |
| 1997 | $8.32 B | 38.36% |
| 1996 | $6.01 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Cardinal Health CAH | $222.12 B | -12.69% | 🇺🇸 USA |
 McKesson MCK | $359.05 B | 41.12% | 🇺🇸 USA |
 Henry Schein
HSIC | $12.66 B | -95.02% | 🇺🇸 USA |
 Owens & Minor
OMI | $10.72 B | -95.79% | 🇺🇸 USA |
 Herbalife HLF | $4.95 B | -98.05% | 🇺🇸 USA |
 Patterson Companies
PDCO | $6.51 B | -97.44% | 🇺🇸 USA |
 CVS Health CVS | $378.96 B | 48.95% | 🇺🇸 USA |
 Rite Aid
RAD | $23.47 B | -90.77% | 🇺🇸 USA |
 Omnicell
OMCL | $1.13 B | -99.55% | 🇺🇸 USA |